TY - JOUR
T1 - Environmentally Controlled Microfluidic System Enabling Immune Cell Flow and Activation in an Endothelialised Skin-On-Chip
AU - Michielon, Elisabetta
AU - Boninsegna, Matteo
AU - Waaijman, Taco
AU - Fassini, Dario
AU - Spiekstra, Sander W.
AU - Cramer, Jeremy
AU - Gaudriault, Pierre
AU - Kodolányi, János
AU - de Gruijl, Tanja D.
AU - Homs-Corbera, Antoni
AU - Gibbs, Susan
N1 - Publisher Copyright:
© 2024 The Author(s). Advanced Healthcare Materials published by Wiley-VCH GmbH.
PY - 2024/11/22
Y1 - 2024/11/22
N2 - Integration of reconstructed human skin (RhS) into organ-on-chip (OoC) platforms addresses current limitations imposed by static culturing. This innovation, however, is not without challenges. Microfluidic devices, while powerful, often encounter usability, robustness, and gas bubble issues that hinder large-scale high-throughput setups. This study aims to develop a novel re-usable multi-well microfluidic adaptor (MMA) with the objective to provide a flexible tool for biologists implementing complex 3D biological models (e.g., skin) while enabling simultaneous user control over temperature, medium flow, oxigen (O2), nitrogen (N2), and carbon dioxide (CO2) without the need for an incubator. The presented MMA device is designed to be compatible with standard, commercially available 6-well multi-well plates (6MWPs) and 12-well transwells. This MMA-6MWP setup is employed to generate a skin-on-chip (SoC). RhS viability is maintained under flow for three days and their morphology closely resembles that of native human skin. A proof-of-concept study demonstrates the system's potential in toxicology applications by combining endothelialised RhS with flowing immune cells. This dynamic setting activates the monocyte-like MUTZ-3 cells (CD83 and CD86 upregulation) upon topical exposure of RhS to a sensitizer, revealing the MMA-6MWP's unique capabilities compared to static culturing, where such activation is absent.
AB - Integration of reconstructed human skin (RhS) into organ-on-chip (OoC) platforms addresses current limitations imposed by static culturing. This innovation, however, is not without challenges. Microfluidic devices, while powerful, often encounter usability, robustness, and gas bubble issues that hinder large-scale high-throughput setups. This study aims to develop a novel re-usable multi-well microfluidic adaptor (MMA) with the objective to provide a flexible tool for biologists implementing complex 3D biological models (e.g., skin) while enabling simultaneous user control over temperature, medium flow, oxigen (O2), nitrogen (N2), and carbon dioxide (CO2) without the need for an incubator. The presented MMA device is designed to be compatible with standard, commercially available 6-well multi-well plates (6MWPs) and 12-well transwells. This MMA-6MWP setup is employed to generate a skin-on-chip (SoC). RhS viability is maintained under flow for three days and their morphology closely resembles that of native human skin. A proof-of-concept study demonstrates the system's potential in toxicology applications by combining endothelialised RhS with flowing immune cells. This dynamic setting activates the monocyte-like MUTZ-3 cells (CD83 and CD86 upregulation) upon topical exposure of RhS to a sensitizer, revealing the MMA-6MWP's unique capabilities compared to static culturing, where such activation is absent.
KW - immune cell activation
KW - immune cell flow
KW - microfluidics
KW - organ-on-chip
KW - reconstructed human skin
KW - skin-on-chip
UR - http://www.scopus.com/inward/record.url?scp=85205544774&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85205544774&partnerID=8YFLogxK
U2 - 10.1002/adhm.202400750
DO - 10.1002/adhm.202400750
M3 - Article
C2 - 39370595
AN - SCOPUS:85205544774
SN - 2192-2640
VL - 13
SP - 1
EP - 17
JO - Advanced Healthcare Materials
JF - Advanced Healthcare Materials
IS - 29
M1 - 2400750
ER -